Summary
This prediction ended on 26.10.21 with a price of €80,000. The BUY prediction by melinda finished with a performance of 11.11%. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Neovacs | - | - | - |
| iShares Core DAX® | -0.922% | -1.078% | 12.165% |
| iShares Nasdaq 100 | 0.371% | -0.556% | 38.622% |
| iShares Nikkei 225® | 2.224% | -2.825% | 19.015% |
| iShares S&P 500 | -0.026% | -0.788% | 28.485% |
According to melinda what are the pros and cons of Neovacs for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year